| Consider the previous two pages first |

Short-acting unmodified insulin |
 |

Consider : |
|
- the median glucose level at the time of the injection to be adjusted
- the median glucose level at the time of the next injection
- the experience of hypoglycaemia or subnormal glucose levels ( <4.0
mmol/l; <70 mg/dl ) between the two injections
|
|
 |

if : |
|
|

 |
glucose levels are high at the beginning
of the relevant period |
|
|

 |
review the insulin dose affecting the previous time period
first |
|
|

Otherwise if : |
|
|

 |
glucose levels are above target, and hypoglycaemia is not an
issue |
|
|

 |
increase insulin dose by 10 %; arrange to monitor and review
result |
|
|

Otherwise if : |
|
|

 |
hypoglycaemia is an issue or glucose levels <4.0 mmol/l (
<70 mg/dl ) |
|
|

 |
decrease insulin dose by 10 %; arrange to monitor and review
result |
|
|

Otherwise if : |
|
|

 |
no simple adjustment is possible; consider more complex
adjustment, or accept the status quo |

Rapid-acting insulin analogues |
 |

Read the box on insulin analogues above |
|

Consider the median post-prandial ( 2-4 h ) glucose level / hypoglycaemia
experience ( and not the next pre-prandial / pre-injection level ) |
|

Proceed otherwise as for short-acting unmodified insulin ( see above ) |

Extended-acting NPH insulin at bed-time |
 |

Consider |
|
- the median glucose level at bed-time
- the median glucose level before breakfast
- any information on glucose levels during the night
|
|
Adjust
insulin dosage as for short-acting unmodified insulin ( see above ) |

Extended-acting NPH insulin at other times |
 |

Consider |
|
- the blood glucose profile over the 12 h after the injection
- the experience of hypoglycaemia or subnormal glucose levels ( <4.0
mmol/l; <70 mg/dl ) over the same time period
- the expected effect of other insulin used in the same time interval
|
|
Adjust
insulin dosage as for short-acting unmodified insulin ( see above ) |